| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | - | 4.52e-05 | 6 | 33 | 2 | 2.160.20.10 | |
| Domain | Pectin_lyas_fold | 4.52e-05 | 6 | 33 | 2 | IPR012334 | |
| Domain | PbH1 | 4.52e-05 | 6 | 33 | 2 | IPR006626 | |
| Domain | PbH1 | 4.52e-05 | 6 | 33 | 2 | SM00710 | |
| Domain | Pectin_lyase_fold/virulence | 8.42e-05 | 8 | 33 | 2 | IPR011050 | |
| Domain | FYVE | 1.19e-03 | 29 | 33 | 2 | PF01363 | |
| Domain | FYVE | 1.19e-03 | 29 | 33 | 2 | SM00064 | |
| Domain | Znf_FYVE-rel | 1.64e-03 | 34 | 33 | 2 | IPR017455 | |
| Domain | Znf_FYVE | 2.05e-03 | 38 | 33 | 2 | IPR000306 | |
| Domain | Znf_FYVE_PHD | 2.19e-03 | 147 | 33 | 3 | IPR011011 | |
| Domain | ZF_FYVE | 2.26e-03 | 40 | 33 | 2 | PS50178 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 4.02e-05 | 410 | 33 | 5 | 26949251 | |
| Pubmed | 1.04e-04 | 16 | 33 | 2 | 28800946 | ||
| Pubmed | Interactome of the negative regulator of nuclear import BRCA1-binding protein 2. | 2.80e-04 | 26 | 33 | 2 | 25820252 | |
| Pubmed | 4.13e-04 | 153 | 33 | 3 | 10718198 | ||
| Pubmed | 4.38e-04 | 378 | 33 | 4 | 34315543 | ||
| Pubmed | 4.97e-04 | 163 | 33 | 3 | 16512683 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.39e-04 | 1105 | 33 | 6 | 35748872 | |
| Pubmed | 7.00e-04 | 41 | 33 | 2 | 8724849 | ||
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 5.30e-04 | 31 | 20 | 2 | 81 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN | 3.42e-05 | 147 | 33 | 4 | M8882 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 4.93e-05 | 323 | 33 | 5 | M2156 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 1.11e-04 | 199 | 33 | 4 | M7924 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 1.13e-04 | 200 | 33 | 4 | M6208 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 1.13e-04 | 200 | 33 | 4 | M9133 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP | 1.13e-04 | 200 | 33 | 4 | M3461 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.67e-06 | 177 | 33 | 4 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.86e-06 | 178 | 33 | 4 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 9.67e-06 | 182 | 33 | 4 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-06 | 182 | 33 | 4 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 148 | 33 | 3 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 156 | 33 | 3 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | facs-Skin-nan-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 164 | 33 | 3 | 7a65c7a6dbe5fb9067f83efafbb7ec8206d79325 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.39e-04 | 164 | 33 | 3 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-04 | 175 | 33 | 3 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-04 | 175 | 33 | 3 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.99e-04 | 177 | 33 | 3 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 3.04e-04 | 178 | 33 | 3 | 67aa17b17da3121c199af45e747c23e2626a9bb2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-04 | 178 | 33 | 3 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-04 | 179 | 33 | 3 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 3.09e-04 | 179 | 33 | 3 | c93711273055a999335ba8d0f6500e4549f46cec | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-04 | 179 | 33 | 3 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-04 | 179 | 33 | 3 | d3d3a9afaac28fa4f2c448c73d79bcbbbea088d7 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-04 | 181 | 33 | 3 | 3fe648db1cb8326066d8bde3ca1287c5c9af19bd | |
| ToppCell | HSPCs-Erythroblasts|HSPCs / Lineage and Cell class | 3.20e-04 | 181 | 33 | 3 | 4ded490f190af7ace343acdf317edc7373484d08 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 3.25e-04 | 182 | 33 | 3 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.35e-04 | 184 | 33 | 3 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.35e-04 | 184 | 33 | 3 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 3.35e-04 | 184 | 33 | 3 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.35e-04 | 184 | 33 | 3 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 3.35e-04 | 184 | 33 | 3 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 3.35e-04 | 184 | 33 | 3 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.35e-04 | 184 | 33 | 3 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 185 | 33 | 3 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 185 | 33 | 3 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 3.57e-04 | 188 | 33 | 3 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 3.63e-04 | 189 | 33 | 3 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 3.63e-04 | 189 | 33 | 3 | 8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.63e-04 | 189 | 33 | 3 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 3.63e-04 | 189 | 33 | 3 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 3.68e-04 | 190 | 33 | 3 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-04 | 191 | 33 | 3 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.86e-04 | 193 | 33 | 3 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.86e-04 | 193 | 33 | 3 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.92e-04 | 194 | 33 | 3 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.92e-04 | 194 | 33 | 3 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.92e-04 | 194 | 33 | 3 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.92e-04 | 194 | 33 | 3 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.92e-04 | 194 | 33 | 3 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.92e-04 | 194 | 33 | 3 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 3.92e-04 | 194 | 33 | 3 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.92e-04 | 194 | 33 | 3 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.92e-04 | 194 | 33 | 3 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.92e-04 | 194 | 33 | 3 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 3.92e-04 | 194 | 33 | 3 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.92e-04 | 194 | 33 | 3 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.92e-04 | 194 | 33 | 3 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.92e-04 | 194 | 33 | 3 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | 356C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-04 | 195 | 33 | 3 | ba8b8831bd5f544f4e25f13949d04e164ecdcd12 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.97e-04 | 195 | 33 | 3 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.03e-04 | 196 | 33 | 3 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.03e-04 | 196 | 33 | 3 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 4.03e-04 | 196 | 33 | 3 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 4.03e-04 | 196 | 33 | 3 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | FLU-Healthy-2|FLU / Virus stimulation, Condition and Cluster | 4.03e-04 | 196 | 33 | 3 | 0f2240a64a1cdd3147f2330f51c871cd0df8c055 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.03e-04 | 196 | 33 | 3 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.09e-04 | 197 | 33 | 3 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.09e-04 | 197 | 33 | 3 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.09e-04 | 197 | 33 | 3 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 4.09e-04 | 197 | 33 | 3 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.09e-04 | 197 | 33 | 3 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 4.16e-04 | 198 | 33 | 3 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | severe-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.16e-04 | 198 | 33 | 3 | 4d8591eabb543ed789f963b507a07c560c76a7c9 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 4.16e-04 | 198 | 33 | 3 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-04 | 198 | 33 | 3 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 4.16e-04 | 198 | 33 | 3 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-04 | 198 | 33 | 3 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 4.22e-04 | 199 | 33 | 3 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 4.22e-04 | 199 | 33 | 3 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | Healthy_donor-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 4.22e-04 | 199 | 33 | 3 | 1311dfd74b991f48b047a439f04f9bf7dfaa0e7a | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 4.22e-04 | 199 | 33 | 3 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 4.22e-04 | 199 | 33 | 3 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 4.22e-04 | 199 | 33 | 3 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 4.22e-04 | 199 | 33 | 3 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | 356C-Lymphocytic-NK_cells-Proliferating_NK_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.22e-04 | 199 | 33 | 3 | e3b69608c834bd8ce6bedde298a2763cc0d7d573 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.22e-04 | 199 | 33 | 3 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-04 | 199 | 33 | 3 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.22e-04 | 199 | 33 | 3 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 4.22e-04 | 199 | 33 | 3 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Stem_cells-Neuroepithelial_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.28e-04 | 200 | 33 | 3 | c9c832f489629b8724501ddfede984b41a7b674d | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Ventral_Precursors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.28e-04 | 200 | 33 | 3 | c8ea0db79b1521f8c90d0d749280c354d3907c3a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.28e-04 | 200 | 33 | 3 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.28e-04 | 200 | 33 | 3 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | severe-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.28e-04 | 200 | 33 | 3 | d341f4e500377a5bef82c24bf64704b981053336 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-Cycling_NK|Lung / Manually curated celltypes from each tissue | 4.28e-04 | 200 | 33 | 3 | 381bafdde6492f020ae93ab8fffa6215c631c570 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-04 | 200 | 33 | 3 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| Disease | empathy measurement | 9.03e-04 | 170 | 33 | 3 | EFO_0009183 | |
| Disease | skin aging measurement | 1.08e-03 | 181 | 33 | 3 | EFO_0008006 | |
| Disease | fatty acid measurement | 1.37e-03 | 436 | 33 | 4 | EFO_0005110 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.51e-03 | 243 | 33 | 3 | EFO_0004612, EFO_0020944 | |
| Disease | Nonorganic psychosis | 2.72e-03 | 69 | 33 | 2 | C0349204 | |
| Disease | serum gamma-glutamyl transferase measurement | 3.26e-03 | 914 | 33 | 5 | EFO_0004532 | |
| Disease | pyruvate measurement | 3.30e-03 | 268 | 33 | 3 | EFO_0010117 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFKNVSCSSLSNSNS | 741 | Q9NR48 | |
| SNDSSELQLTNFCLL | 461 | Q5JWR5 | |
| SDLCNSASSSSVLLN | 296 | Q8N6Q3 | |
| LNLASQCFQLSSLFT | 421 | Q86U06 | |
| SSFLALNQASLISRC | 11 | O75951 | |
| NSESSLKNRSAFCSD | 811 | Q8IWI9 | |
| TTLNSRCSVLAAANS | 476 | P33992 | |
| NSSTSENRASCSFFL | 71 | Q8NI17 | |
| SLQSLNSNSVSQASC | 581 | P0C7T5 | |
| FANSFSRNLTLTCNL | 656 | Q8NCM2 | |
| AQNCQTFSSLSCLSA | 301 | Q14153 | |
| TALRFNSSSLQCQNS | 756 | Q9UIW2 | |
| SDFSNSLDSLCNRIF | 471 | Q93074 | |
| LSSSSNCLSDTNQNK | 341 | P10070 | |
| SSLNSSLNLLDTSFC | 176 | Q02509 | |
| SASNSFSRLHCRNAN | 6 | Q9NUJ7 | |
| QRLCVLFSSSSAQSS | 1216 | Q9Y2I7 | |
| LCSAAQNSRLSAQRT | 536 | Q86XA9 | |
| CDLNNLSSFATSVLR | 446 | Q53R41 | |
| NTLLSRTDSCSSAQA | 716 | Q96PD2 | |
| LQSCSLRSSENSINL | 466 | Q9H9A7 | |
| CNNLRTSNSSKSTLG | 551 | Q9BZQ2 | |
| FLNLRSSLSNCNSDS | 261 | Q8NEM2 | |
| LCSNLESATYSNRAL | 221 | Q15785 | |
| KDCVSNNSLSSNASL | 681 | O14924 | |
| GSSANLRNSCLFLQS | 1001 | Q12767 | |
| LQSFCDSSRDRNLTN | 1191 | Q12767 | |
| SSCLSSRANSNLTLT | 141 | Q6N022 | |
| DSQSSNQFSLVSRCL | 246 | O43543 | |
| NRALCSQLFSESSQS | 161 | Q9P272 | |
| ICLSNSFQRQLSSAT | 1521 | O60346 | |
| STRQALLFNFLSACS | 361 | Q9C0K1 | |
| SNSLNSRLFSLLCDN | 1031 | Q6R2W3 | |
| NLASSCTLDSALNAA | 261 | Q6NUS6 | |
| ALCSSRQSQQTSSLL | 1236 | Q68DK2 |